AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH FIBROTIC LUNG DISEASE

Registry ID

RIN-PF-302

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

UNITED THERAPEUTICS CORPORATION

Start date

2024-12-30

Last update

2024-06-26

Conditions

• LUNG DISEASE

Related clinical trials

• REDUCING RESPIRATORY SYMPTOMS OF PULMONARY IRRADIATION IN INTERSTITIAL LUNG DISEASE (RESPIRE-ILD): A 2X2 FACTORIAL RANDOMIZED PHASE II TRIAL TESTING N-ACETYL CYSTEINE AND DEXAMETHASONE
• PIONEERING PRE- AND POST-OPERATIVE INTEGRATIVE CARE TO IMPROVE THORACIC CANCER QUALITY OF CARE: THE THORACIC PERI-OPERATIVE INTEGRATIVE SURGICAL CARE EVALUATION (POISE) TRIAL - STAGE III
• PULMONARY IMAGING REGISTRY (PIMREGISTRY) FOR INNOVATION IN RESPIRATORY MEDICINE
• IMAGING MEASURES OF RESPIRATORY HEALTH REGISTRY (IMRH)
• A PHASE 2B, MULTICENTER, RANDOMIZED, OPEN-LABEL, CONTROLLED, 3-ARM STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP607 IN PREVENTING CHRONIC LUNG DISEASE THROUGH 12 MONTHS CORRECTED AGE COMPARED TO STANDARD NEONATAL CARE IN EXTREMELY PREMATURE INFANTS.
• SINGLE-CENTRE STUDY EXPLORING THE UTILITY OF HYPERPOLARIZED 129XE MAGNETIC RESONANCE IMAGING IN HEALTHY VOLUNTEERS AND PATIENTS WITH LUNG DISEASE

View on source registry